Modulation of the human cytokine response by interferon lambda-1 (IFN-λ1/IL-29) (original) (raw)

• Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003; 4: 69–77.
  Article CAS Google Scholar
• Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE et al. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003; 4: 63–68.
  Article CAS Google Scholar
• Donnelly RP, Sheikh F, Kotenko SV, Dickensheets H . The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J Leukoc Biol 2004; 76: 314–321.
  Article CAS Google Scholar
• Dumoutier L, Lejeune D, Hor S, Fickenscher H, Renauld JC . Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3. Biochem J 2003; 370 (Part 2): 391–396.
  Article CAS Google Scholar
• Nadeau OW, Domanski P, Usacheva A, Uddin S, Platanias LC, Pitha P et al. The proximal tyrosines of the cytoplasmic domain of the beta chain of the type I interferon receptor are essential for signal transducer and activator of transcription (Stat) 2 activation. Evidence that two Stat2 sites are required to reach a threshold of interferon alpha-induced Stat2 tyrosine phosphorylation that allows normal formation of interferon-stimulated gene factor 3. J Biol Chem 1999; 274: 4045–4052.
  Article CAS Google Scholar
• Renauld JC . Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat Rev Immunol 2003; 3: 667–676.
  Article CAS Google Scholar
• Meager A, Visvalingam K, Dilger P, Bryan D, Wadhwa M . Biological activity of interleukins-28 and -29: comparison with type I interferons. Cytokine 2005; 31: 109–118.
  Article CAS Google Scholar
• Igietseme JU, Ananaba GA, Bolier J, Bowers S, Moore T, Belay T et al. Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development. J Immunol 2000; 164: 4212–4219.
  Article CAS Google Scholar
• de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE . Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209–1220.
  Article CAS Google Scholar
• de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174: 915–924.
  Article CAS Google Scholar
• de Waal Malefyt R, Yssel H, de Vries JE . Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 1993; 150: 4754–4765.
  CAS PubMed Google Scholar
• Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S . Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150: 353–360.
  CAS Google Scholar
• Kadowaki N, Liu YJ . Natural type I interferon-producing cells as a link between innate and adaptive immunity. Hum Immunol 2002; 63: 1126–1132.
  Article CAS Google Scholar
• Le Bon A, Tough DF . Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 2002; 14: 432–436.
  Article CAS Google Scholar
• Kadowaki N, Antonenko S, Lau JY, Liu YJ . Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med 2000; 192: 219–226.
  Article CAS Google Scholar
• Simovic MO, Bonham MJ, Abu-Zidan FM, Windsor JA . Anti-inflammatory cytokine response and clinical outcome in acute pancreatitis. Crit Care Med 1999; 27: 2662–2665.
  Article CAS Google Scholar
• Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, Kurokawa A . The ratio of interleukin-6 to interleukin-10 correlates with severity in patients with chest and abdominal trauma. Am J Emerg Med 1999; 17: 548–551.
  Article CAS Google Scholar
• Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, Kurokawa A . Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 1999; 27: 1262–1264.
  Article CAS Google Scholar
• Gallagher G, Dickensheets H, Eskdale J, Izotova LS, Mirochnitchenko OV, Peat JD et al. Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun 2000; 1: 442–450.
  Article CAS Google Scholar
• Gallagher G, Eskdale J, Jordan W, Peat J, Campbell J, Boniotto M et al. Human interleukin-19 and its receptor: a potential role in the induction of Th2 responses. Int Immunopharmacol 2004; 4: 615–626.
  Article CAS Google Scholar
• Liao SC, Cheng YC, Wang YC, Wang CW, Yang SM, Yu CK et al. IL-19 induced Th2 cytokines and was up-regulated in asthma patients. J Immunol 2004; 173: 6712–6718.
  Article CAS Google Scholar
• Oral HB, Kotenko SV, Yilmaz M, Mani O, Zumkehr J, Blaser K et al. Regulation of T cells and cytokines by the interleukin-10 (IL-10)-family cytokines IL-19, IL-20, IL-22, IL-24 and IL-26. Eur J Immunol 2006; 36: 380–388.
  Article CAS Google Scholar
• Jordan WJ, Eskdale J, Boniotto M, Lennon GP, Peat J, Campbell JD et al. Human IL-19 regulates immunity through auto-induction of IL-19 and production of IL-10. Eur J Immunol 2005; 35: 1576–1582.
  Article CAS Google Scholar
• Le Bon A, Etchart N, Rossmann C, Ashton M, Hou S, Gewert D et al. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol 2003; 4: 1009–1015.
  Article CAS Google Scholar
• Le Bon A, Schiavoni G, D'Agostino G, Gresser I, Belardelli F, Tough DF . Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001; 14: 461–470.
  Article CAS Google Scholar
• Durand V, Wong SY, Tough DF, Le Bon A . Shaping of adaptive immune responses to soluble proteins by TLR agonists: a role for IFN-alpha/beta. Immunol Cell Biol 2004; 82: 596–602.
  Article CAS Google Scholar
• Lopez CB, Moltedo B, Alexopoulou L, Bonifaz L, Flavell RA, Moran TM . TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses. J Immunol 2004; 173: 6882–6889.
  Article CAS Google Scholar
• Uematsu S, Sato S, Yamamoto M, Hirotani T, Kato H, Takeshita F et al. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-med. J Exp Med 2005; 201: 915–923.
  Article CAS Google Scholar
• Hertzog PJ, O'Neill LA, Hamilton JA . The interferon in TLR signaling: more than just antiviral. Trends Immunol 2003; 24: 534–539.
  Article CAS Google Scholar
• Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A, Latz E et al. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med 2003; 198: 1043–1055.
  Article CAS Google Scholar
• Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003; 4: 491–496.
  Article CAS Google Scholar
• Sheppard P, Presnell SR, Fox B, Gilbert T, Haldeman B, Grant FJ . Interferon-like protein, Zcyto21. United States Patent Application no. 002003963 April 4, 2002; 2002.
• Radich JP, Mao M, Stepaniants S, Biery M, Castle J, Ward T et al. Individual-specific variation of gene expression in peripheral blood leukocytes. Genomics 2004; 83: 980–988.
  Article CAS Google Scholar
• Riedemann NC, Guo RF, Hollmann TJ, Gao H, Neff TA, Reuben JS et al. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis. FASEB J 2004; 18: 320–322.
  Article Google Scholar
• Gabay C . Interleukin-6 and chronic inflammation. Arthritis Res Ther 2006; 8 (Suppl 2): S3.
  Article Google Scholar
• Cassatella MA, Tamassia N, Crepaldi L, McDonald PP, Ear T, Calzetti F et al. Lipopolysaccharide primes neutrophils for a rapid response to IL-10. Eur J Immunol 2005; 35: 1877–1885.
  Article CAS Google Scholar
• Dang PM, Elbim C, Marie JC, Chiandotto M, Gougerot-Pocidalo MA, El-Benna J . Anti-inflammatory effect of IL-10 on neutrophil respiratory burst involves inhibition of GM-CSF produced p47PHOX phospohrylation through a decrease in ERK1/2 activity. FASEB J 2006; 20: 1504–1506.
  Article CAS Google Scholar
• McLoughlin RM, Jenkins BJ, Grail D, Williams AS, Fielding CA, Parker CR et al. IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. Proc Natl Acad Sci USA 2005; 102: 9589–9594.
  Article CAS Google Scholar
• Kaplanski G, Marin V, Montero-Julian F, Mantovani A, Farnarier C . IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol 2003; 24: 25–29.
  Article CAS Google Scholar
• Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A . Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683–765.
  Article CAS Google Scholar
• Beebe AM, Cua DJ, de Waal Malefyt R . The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 2002; 13: 403–412.
  Article CAS Google Scholar
• Itoh K, Hirohata S . The role of IL-10 in human B cell activation, proliferation, and differentiation. J Immunol 1995; 154: 4341–4350.
  CAS PubMed Google Scholar
• Levy Y, Brouet JC . Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Invest 1994; 93: 424–428.
  Article CAS Google Scholar
• Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992; 89: 1890–1893.
  Article CAS Google Scholar
• Defrance T, Vanbervliet B, Briere F, Durand I, Rousset F, Banchereau J . Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med 1992; 175: 671–682.
  Article CAS Google Scholar
• Curotto de Lafaille MA, Lafaille JJ . CD4(+) regulatory T cells in autoimmunity and allergy. Curr Opin Immunol 2002; 14: 771–778.
  Article CAS Google Scholar
• Levings MK, Bacchetta R, Schulz U, Roncarolo MG . The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. Int Arch Allergy Immunol 2002; 129: 263–276.
  Article CAS Google Scholar
• Wolk K, Witte E, Reineke U, Witte K, Friedrich M, Sterry W et al. Is there an interaction between interleukin-10 and interleukin-22? Genes Immun 2005; 6: 8–18.
  Article CAS Google Scholar
• Koks S, Kingo K, Ratsep R, Karelson M, Silm H, Vasar E . Combined haplotype analysis of the interleukin-19 and -20 genes: relationship to plaque-type psoriasis. Genes Immun 2004; 5: 662–667.
  Article CAS Google Scholar
• Li HH, Lin YC, Chen PJ, Hsiao CH, Lee JY, Chen WC et al. Interleukin-19 upregulates keratinocyte growth factor and is associated with psoriasis. Br J Dermatol 2005; 153: 591–595.
  Article CAS Google Scholar
• Otkjaer K, Kragballe K, Funding AT, Clausen JT, Noerby PL, Steiniche T et al. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis. Br J Dermatol 2005; 153: 911–918.
  Article CAS Google Scholar
• Jordan WJ, Ritter MA . Optimal analysis of composite cytokine responses during alloreactivity. J Immunol Methods 2002; 260: 1–14.
  Article CAS Google Scholar
• Langenkamp A, Messi M, Lanzavecchia A, Sallusto F . Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol 2000; 1: 311–316.
  Article CAS Google Scholar